 Bronchodilator treatment reversible chronic obstructive airways disease effect weeks treatment inhaled terbutaline times day optimised doses theophylline day combination theophylline terbutaline placebo randomised double blind trial Thirty patients reversible chronic airflow obstruction mean forced expiratory volume second litres study Patients non-infective exacerbations airflow obstruction additional bronchodilator treatment treatment failures Such treatment failure patients placebo patients theophylline patients terbutaline patients drugs Mean daily peak flow readings combination drugs terbutaline placebo combination terbutaline theophylline superior drug inhaled terbutaline superior much place management patients reversible obstructive airways disease